**Ib. Cov ntsiab cai ntawm cov khoom thiab cov kev xav tau tshwj xeeb **
Cov hlab ntshav no siv ** 3.2% (0.109 mol / L) lossis 3.8% sodium citrate ** ua cov tshuaj tiv thaiv. Los ntawm tshwj xeeb chelating calcium ions nyob rau hauv cov ntshav, nws reversibly inhibits cov txheej txheem coagulation, muab lub hauv paus ruaj khov rau * hauv vitro * coagulation muaj nuj nqi tsom xam. Nws cov kev cai tshwj xeeb tseem ceeb suav nrog:
- **Strict Blood-rau-Anticoagulant Ratio:** Nws yog ib qho tseem ceeb kom ntseeg tau tias qhov sib piv ** 9: 1 ntawm cov ntshav rau cov tshuaj anticoagulant**. Tsis txaus lossis ntau dhau ntawm cov ntshav ntim yuav cuam tshuam ncaj qha rau calcium ion concentration, ua rau lub sij hawm tsis zoo los yog luv luv coagulation thiab cuam tshuam cov txiaj ntsig raug.
- **Sim sij hawm ua cov qauv:** Kev ntsuam xyuas yuav tsum ua kom tiav nyob rau hauv lub sij hawm teev tom qab sau los xyuas kom meej lub stability ntawm coagulation yam.
** II. Cov cheeb tsam tseem ceeb ntawm daim ntawv thov **
Lub raj no yog tsim tshwj xeeb rau kev ua haujlwm coagulation-cov kev ntsuas cuam tshuam uas xav tau **plasma**, suav nrog:
- **Kev kuaj ntshav coagulation:** Lub Sijhawm Prothrombin (PT), Kev Ntsuas Kev Ntsuas Thoob Ntiaj Teb (INR), Lub Sijhawm Ua Haujlwm Ib Feem Thromboplastin (APTT)
- **Coagulation Factor Activity Assays** (eg, Factors II, V, VII, VIII, IX, X, XI, XII)
- ** Kev Saib Xyuas Kev Tiv Thaiv Kev Tiv Thaiv Kab Mob ** (xws li Warfarin, Heparin)
- **Coagulation Factor Inhibitor Screening**
- **Qee Methodologies for Fibrinolytic System Testing** (eg, D-dimer, Fibrinogen Degradation Products)
** III. Khoom Specifications thiab cov ntsiab lus tseem ceeb ua haujlwm **
- **Anticoagulant Type:** **3.2% (pom zoo) lossis 3.8% Sodium Citrate**
- **Identification Feature:** Feem ntau txheeb xyuas los ntawm **lub teeb xiav lub hau** raws li tus qauv thoob ntiaj teb.
- **Cov txheej txheem ua haujlwm tseem ceeb:**
1. ** Venipuncture thiab Blood Collection:** Ua kom cov ntshav khiav zoo thiab tsis txhob muaj cov kua dej paug. Sau lub raj rau kab ntawv kawm tiav kom paub meej qhov sib piv ** 9: 1 **.
2. **Tam sim ntawd thiab tag nrho Mixing:** Tom qab sau, maj mam invert lub raj **3-4 zaug** tam sim ntawd los xyuas kom meej tag nrho cov tshuaj anticoagulant nrog cov ntshav, tiv thaiv lub zos clotting los yog ua kom tiav.
3. **Specimen Processing:**
- Kev sim lossis kev sib cais ntawm cov ntshav los ntawm centrifugation yuav tsum ua tiav ** hauv 1–4 teev** (raws li lub chaw soj nstuam Cov Txheej Txheem Kev Ua Haujlwm).
- Centrifugation Conditions: Feem ntau centrifuge ntawm **1500–2500 RCF rau 10–15 feeb** kom tau txais platelet-plasma tsis zoo (platelet suav <10 x 10⁹/L).
4. **Kev khaws cia thiab thauj:** Yog tias qhov ntsuas tau ua tiav hauv 4 teev ntawm kev sib cais, cov ntshav tuaj yeem khaws cia hauv chav sov; txwv tsis pub, nws yuav tsum khaws cia ntawm ** 2-8℃**, tab sis tsis pub tshaj 24 teev. Rau lub sijhawm ntev - khaws cia, plasma yuav tsum khov ntawm -20℃lossis -80 degree, tsis txhob rov qab khov-thaw mus.


Peb Daim Ntawv Pov Thawj
ISO13485, FSC, MSDS, FDA.
tuam txhab philosophy
North America 15%, South America 15%, Southern Europe10%, South Asia 10%, Kev Lag Luam Hauv Tsev 10%, Mid East 6%, Eastern Europe 5%, Southeast Asia 5%


FAQ

01.Peb tuaj yeem lav qhov zoo li cas?
Ib txwm soj ntsuam zaum kawg ua ntej ua zaub mov xa tuaj; lub tshuab nqus tsev vacuum
27 xyoo kev tsim khoom tsim kev paub
02.Koj tuaj yeem yuav dab tsi ntawm peb?
03.Koj puas muaj daim ntawv pov thawj?
Cim npe nrov: pov tseg lub tshuab nqus tsev pt ntshav sau tube, Tuam Tshoj, lwm tus neeg, manufacturers, hoobkas, customized, lag luam wholesale, nqe, pheej yig, kev muag, hauv Tshuag, yuav luv nqi










